Acetazolamide in Hydrocephalus Management
The efficacy of treatment with acetazolamide (100 mg/kg/day) without frusemide in arresting post-hemorrhagic ventricular dilatation was evaluated in 3 infants at the Hammersmith Hospital, London, UK.
Saved in:
| Main Author: | J Gordon Millichap |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1995-02-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dent’s disease: case series from a single center
by: Hilal Yaşar, et al.
Published: (2024-11-01) -
Intramuscular synthol injections cause hypercalcemia in long-term observation: a case report study
by: Magdalena Markowska, et al.
Published: (2025-08-01) -
A novel homozygous W99G mutation in CLDN-16 gene causing familial hypomagnesemic hypercalciuric nephrocalcinosis in Turkish siblings
by: Caner Alparslan, et al.
Published: (2018-02-01) -
Modern Approaches to the Management of Children with Hypophosphatasia
by: Aleksander A. Baranov, et al.
Published: (2023-08-01) -
X-linked hypophosphatemic rickets and nephrocalcinosis: clinical characteristics of a single-center pediatric cohort in North America before and after burosumab
by: Neil J. Paloian, et al.
Published: (2024-08-01)